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Screening and correcting reversible causes of cardiac arrest (CA) are an essential part of 
cardiopulmonary resuscitation (CPR). Point-of-care (POC) laboratory analyses are used for 
screening pre-arrest pathologies, such as electrolyte disorders and acid-base balance 
disturbances. The aims of this study were to compare the intraosseous (IO), arterial and 
central venous POC values during CA and CPR and to see how the CPR values reflect the pre-
arrest state.  
 
Methods 
We performed an experimental study on 23 anaesthetised pigs. After induction of ventricular 
fibrillation (VF), we obtained POC samples from the IO space, artery and central vein 
simultaneously at three consecutive time points. We observed the development of the values 
during CA and CPR and compared the CPR values to the pre-arrest values. 
 
Results 
The IO, arterial and venous values changed differently from one another during the course of 
CA and CPR. Base excess and pH decreased in the venous and IO samples during untreated VF, 
but in the arterial samples, this only occurred after the onset of CPR. The IO, arterial and 
venous potassium values were higher during CPR compared to the pre-arrest arterial values 
(mean elevations 4.4 mmol/l (SD 0.72), 3.3 mmol/l (0.78) and 2.8 mmol/l (0.94), respectively). 
 
Conclusions 
A dynamic change occurs in the common laboratory values during CA and CPR. POC analyses 
of lactate, pH, sodium and calcium within IO samples are not different from analyses of arterial 
or venous blood. Potassium values in IO, arterial and venous samples during CPR are higher 
than the pre-arrest arterial values. 
 
Institutional protocol numbers 
The Finnish National Animal Experiment Board (ESAVI/1077/04.10.07/2016).  
The hospital board (HUS/215/2016, §7 30.3.2016). 
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Intra-osseous access; Cardiopulmonary resuscitation; Resuscitation; Point-of-care; Laboratory 
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Introduction 
During cardiopulmonary resuscitation (CPR), screening and correcting reversible causes of 
cardiac arrest (CA) are an essential part of the advanced life support algorithm [1]. Information 
about a patient’s history and events prior to CA is crucial, but supplementary information 
about the pre-arrest pathologies, such as electrolyte disorders, acid-base balance 
disturbances or bleeding, could be easily and rapidly gathered with point-of-care (POC) 
laboratory analyses. The European Resuscitation Council (ERC) Guidelines for Resuscitation 
2015 state that electrolyte and metabolic disorders should be screened with biochemical tests 
during CPR, even though the results might be difficult to interpret [1]. 
 
The circulatory conditions change drastically during CA and CPR compared to the pre-arrest 
state, and it is currently unclear how the blood samples taken during CPR reflect the pre-arrest 
situation. Additionally, blood samples taken from different sources (artery, vein) have 
different acid-base balance and blood gas values during different phases of CA and CPR [2–4]. 
Thus, it has been suggested that central venous blood could provide a better estimation than 
arterial blood of the tissue acid-base state during CA [5]. Indeed, tissue acidosis is not 
detectable in the peripheral blood until at least some perfusion is re-established through CPR 
[3].  
 
Intraosseous (IO) access is used as an optional vascular route for critically ill patients, 
especially in the pre-hospital setting, but based on current knowledge, only for administering 
medication and fluids [6–8]. The use of an IO blood sample for intra-arrest POC testing has 
appeal, given the problems with obtaining arterial or venous samples from unstable patients 
in difficult environments. POC analyses of IO samples have proven to be feasible in several 
studies, but it is still unclear whether the IO values agree with arterial and venous values, 
especially during resuscitation and in low-flow states [9–16]. Until now, only one study 
evaluating the analysis of IO samples during human CPR has been published [9].  The 
observational prospective study compared venous and IO POC samples from 17 patients 
during CPR in emergency department (ED). Acceptable agreement was described between IO 
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and venous results for pH, bicarbonate, sodium and base excess, but the small amount of 
observations limits the confidence. High mortality (7 in ED and 13 during hospital stay) and 
missing information about the initial rhythms or the delay from the onset of CA to the POC 
sampling impair the applicability of the results. 
 
Accordingly, we designed an experimental study to observe and compare the changes in IO, 
arterial and central venous POC values of blood gases, acid-base balance, lactate, glucose, 
electrolytes and haemoglobin during experimental CPR. We hypothesised that blood samples 
from the IO route would not differ from arterial and venous samples in estimating electrolyte 
and acid-base values during CPR. Additionally, we compared IO, arterial and venous samples 
taken during CPR to the pre-arrest arterial values to see which one of them best reflects the 
pre-arrest state.  
 
Methods 
 
This experimental animal study was conducted in the Research and Development Unit of 
Helsinki University Hospital, Helsinki, Finland between March and June 2016.  
The Finnish National Animal Experiment Board (ESAVI/1077/04.10.07/2016) and the hospital 
board (HUS/215/2016, §7 30.3.2016) approved the study plan. The study adhered to the 
ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines. 
 
Preparation and monitoring 
 
We included 23 healthy landrace pigs of both genders weighing 26 – 38 kg. Prior to the 
procedural day, the animals had free access to food and water. The animals were pre-
medicated with a mixture of ketamine (600 mg), atropine (1 mg), and medetomide (2 mg), 
which was injected intramuscularly 30 minutes before the procedure. We cannulated a 
peripheral vein in the ear and started an infusion of Ringer’s acetate (Ringer-Acetate Baxter 
Medical, Kista, Sweden). We induced anaesthesia with intravenous propofol (20–100 mg) and 
fentanyl (100–200μg) and intubated (endotracheal tube size 6.0) and mechanically ventilated 
(Servo Ventilator 900C, Siemens-Elema, Solna, Sweden) the pigs with 21% oxygen (O2) before 
inducing cardiac arrest. Ventilation was regulated, with a target end-tidal carbon dioxide 
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(etCO2) level of 5% (5,1 kPa). The arterial oxygen saturation (SpO2) was monitored with a pulse 
oximeter attached to the pig’s tail. Anaesthesia was maintained with propofol infusion 
(20 mg/ml, 5 – 25 ml/h). An oesophageal temperature probe was inserted, and an external 
radiant heater and a warming mattress were used to maintain a normal body temperature 
(38–39 °C). The haemodynamic and respiratory variables were monitored with a Datex-
Ohmeda AS/3 monitor (GE Healthcare, Helsinki, Finland). 
 
We surgically prepared the femoral artery and cannulated it with a vascular sheath (Arrow, 
size 7 Fr, length 15 cm) to take arterial blood samples and measure invasive blood pressure. 
We cannulated the internal jugular vein using Seldinger’s technique and inserted an 
introducer catheter (Arrow, size 7 Fr) for venous blood sampling, medication and pacemaker 
catheter insertion. A temporary balloon-tipped pacing wire was inserted into the right 
ventricular wall, and the correct placement was confirmed by initiating pacing with a 
Medtronic 5348 Single Chamber Temporary Pacemaker (Medtronic Inc., Minneapolis, MN, 
USA).  
 
Experimental procedures 
 
We induced ventricular fibrillation (VF) by delivering a 4 V electrical current to the pacing wire. 
The sedation was ceased a few minutes before inducing CA. After seven minutes of untreated 
VF, we started CPR with mechanical chest compressions (LUCAS™ Chest Compression System, 
Lund, Sweden) with a frequency of 100 compressions / min and manual bag valve ventilation 
(Laerdal Silicone Resuscitator, Norway) with a frequency of 10 ventilations / min. The pigs 
were randomised using sealed envelopes to be ventilated either with approximately 50% or 
100% inspired oxygen for another study protocol, which compared the effect of a 50% or 100% 
inspired oxygen fraction (FiO2) during CPR on brain oxygenation and post-CA mitochondrial 
function [17]. The FiO2 was titrated with continuous monitoring of inspiratory oxygen using a 
D-lite gas sampler and flow sensor (GE Healthcare, IL, USA) attached between the 
endotracheal tube and the ventilation bag, and the oxygen flow (2 –15 l/min) was adjusted 
accordingly to reach the desired FiO2 level. After six minutes of CPR, we performed 
defibrillation with a Zoll M-series defibrillator (ZOLL Medical Corporation, Chelmsford, MA, 
USA). If sinus rhythm was not achieved, we administered a 1-mg bolus of adrenaline 
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intravenously and continued CPR. We continued resuscitation with defibrillations (if still in a 
shockable rhythm) and boluses of adrenaline every two minutes until the return of 
spontaneous circulation (ROSC) or for at least 20 minutes (i.e. 27 minutes from cardiac arrest). 
ROSC was defined as the sustained restoration of an organised cardiac rhythm with a mean 
arterial pressure (MAP) of more than 50 mmHg. If the animal had a clear transient pulsating 
rhythm but recurring VF, we performed stacked immediate defibrillations. The MAP target 
after ROSC was above 70 mmHg with an infusion of noradrenaline (0.04 mg/ml). In the end of 
the experiment, we euthanised the pigs with a lethal dose of potassium chloride (40 mmol).  
 
Blood samples 
 
We took POC samples from the femoral artery, central vein and IO space simultaneously at 
four consecutive time points: before inducing VF (T0), after five minutes of untreated VF (T1), 
5 minutes after initiation of CPR (T2) and 10 minutes after ROSC (T3) (Fig 1.). 
To take a blood sample from the IO space, we inserted a 15G 25-mm needle into the proximal 
tibia using an EZ-IO® device (Teleflex® Inc., PA, USA). We inserted a new needle for each 
sample because, due to clotting, it was impossible to draw repeated blood samples using the 
same needle, and we did not want to flush the needle and risk contaminating the samples 
with saline. We drew the initial 0.5–2 ml of blood from the IO space by using a 3-ml dry heparin 
(70 IU) blood gas syringe (RAPIDLyte®, Siemens Healthcare Diagnostics GmbH®, Erlangen, 
Germany) without discarding any waste blood. We analysed all samples immediately using an 
i-STAT® handheld point-of-care device (Abbott Point of Care Inc., Princeton, NJ, USA) with 
CG4+ and CG8+ cartridges. We analysed the following parameters, which we consider to be 
the values of interest in critically ill patients and during CA: partial pressure of oxygen (pO2), 
partial pressure of carbon dioxide (pCO2), base excess (BE), standard bicarbonate (HCO3), pH, 
lactate, sodium (Na), potassium (K), ionised calcium (iCa), glucose and haemoglobin (Hb). 
 
Statistical analysis 
 
We plotted the laboratory parameters at different time points to demonstrate the 
development of the values during the course of CA and CPR. The data are presented as the 
means with 95% confidence intervals (Fig. 2 and 3).  
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 To assess how the blood samples taken during resuscitation reflect the pre-arrest state, we 
calculated the individual differences in the laboratory parameters between the resuscitation 
samples (IO, artery and vein) and arterial baseline samples (golden standard representing the 
pre-arrest state) (Fig. 4 and 5). 
 
We drew the figures with GraphPad Prism version 7.0c (GraphPad Software, Inc., California, 
USA). 
 
Results 
  
VF induction was successful in 23 pigs, and 16 of them reached ROSC. During the data analysis, 
we decided to exclude baseline (T0) IO results from 8 pigs and the VF (T1), resuscitation (T2) 
and ROSC (T3) IO results from 11 pigs because of missing information regarding the IO 
sampling side (left vs. right leg). We determined that it was possible that if the IO samples 
were taken from the same leg where we had inserted the femoral artery catheter, the partial 
obstruction of arterial blood flow in the main artery of the limb could have distorted the IO 
results. To evaluate the possible bias, we performed a sensitivity analysis with the complete 
set of samples (i.e. including the previously excluded IO-results). This new analysis showed no 
major difference compared to the original analysis. (Suppl. 1). 
 
Change in IO, arterial and venous values during the course of CA and CPR  
 
The blood gas, acid-base balance, lactate, glucose, electrolytes and haemoglobin values during 
CA and CPR are shown in Figures 2 and 3. Lactate levels increased in the IO samples during VF. 
Such a change was not evident in the arterial and venous samples, in which the increase 
occurred only during CPR. Decreases in pH and BE were evident in the IO and venous samples 
during VF, but they only occurred within the arterial samples after the initiation of CPR. 
Potassium levels were higher and sodium levels were lower in the IO samples compared to 
those in venous and arterial samples at all studied time points. Elevated glucose levels during 
CPR were seen in the arterial and venous samples but not in the IO samples. The IO values of 
pO2 and pCO2 closely followed the venous values. 
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Comparison of IO, arterial and venous values during CPR with the pre-arrest arterial 
values 
 
The changes in the studied parameters are shown in Figures 4 and 5. The electrolyte and acid-
base values from all sampling sites during CPR differed markedly from the pre-arrest values. 
Most changes followed the expected physiological pattern. Potassium values from all 
sampling sites during CPR were clearly higher than those before VF. Glucose values were 
elevated in the venous and arterial samples, whereas in the IO samples they resembled the 
pre-arrest state. In contrast to the arterial and venous values, the IO values of BE and HCO3 
represented the pre-arrest state. POC analyses of haemoglobin revealed a large variance in 
the results, but there was no significant difference between the sampling sites. 
 
Discussion 
 
Our data show that during experimental CPR, POC analyses from IO access may act as a 
reasonable substitute for arterial and venous samples for quantifying lactate, pH, sodium and 
calcium levels. Interestingly, the IO levels of oxygen and carbon dioxide closely resembled the 
venous levels but were, as expected, very different from those in the arterial samples. 
However, the IO values of potassium and glucose appeared to differ from the arterial and 
venous levels. If our results are replicated in patients, they may suggest a limited but 
important role for the use of POC analysis for IO samples during clinical CPR.    
 
The reliability of POC analysis of IO blood samples has become a relevant issue because of the 
wider implementation of IO devices and POC diagnostics in pre-hospital and emergency care. 
Our study is the first to compare IO samples with simultaneous arterial and venous samples 
during different stages of resuscitation. Previous studies have compared IO samples to venous 
samples in experimental resuscitation models [13–15, 18]. In our own previous study, the 
agreement of IO, arterial and venous blood samples was studied in 31 healthy volunteers [16]. 
Recently, Tallman et al. reported a prospective human study in which POC IO blood samples 
were compared with venous samples of 17 patients arriving to the hospital in CA and being 
resuscitated [9].  
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According to the ERC Resuscitation Guidelines 2015, the potential causes or aggravating 
factors that a specific treatment addresses must be considered during CA [1]. These include 
electrolyte disorders, acidosis and other metabolic disorders, which can be detected by 
biochemical tests or suggested by the patient’s medical history. The guidelines state that 
during CA, arterial blood gas values may be misleading and are unrelated to the tissue acid-
base state; hence, analysis of central venous blood might provide a better estimation of tissue 
pH [1]. Accordingly, the degree of detected acidaemia is dependent on the timing of the blood 
sample, the degree of tissue acidosis and the effectiveness of wash-out with CPR [19]. 
Interestingly, our study shows the previously identified phenomenon of the paradoxical 
elevation of BE and pH in arterial samples during VF [2–4]. Because acidosis shifts potassium 
from the intracellular space, the effects of changes in serum pH must be considered in the 
evaluation of potassium levels [20]. According to the guidelines, there is little or no evidence 
supporting the treatment of electrolyte abnormalities during CA [20]. Our study shows that 
potassium values during CPR from different sampling sites are, on average, 2.8 – 4.4 mmol/l 
higher than those before cardiac arrest. This indicates that hyperkalaemia during CPR does 
not necessarily refer to elevated potassium levels before CA, which renders the diagnosis of 
pre-arrest hyperkalaemia as a cause of the CA particularly difficult. Since the current 
resuscitation guidelines recommend considering buffer therapy during CPR only in cases of 
hyperkalaemia and tricyclic overdose, the implications for POC blood analyses during 
resuscitation should be re-evaluated. 
 
An interesting issue is the prognostic value of certain laboratory parameters and whether they 
can provide some supporting information for decision-making during CPR. Spindelboeck et al. 
prospectively studied the arterio-alveolar CO2 difference (AaDCO2) in 115 patients being 
resuscitated from out-of-hospital CA (OHCA) and found that lower AaDCO2 values predicted 
survival until hospital admission [21]. In this study, we did not compare the POC values 
between the animals not reaching ROSC and those that did due to the small sample size.  
 
This study shows that IO, arterial and venous values change differently during CA and CPR. The 
reasons for the differences are not evident. IO blood can be considered to be like capillary 
blood and thus, during circulatory arrest represent better the tissue metabolism compared to 
the stationary blood in arteries and veins. Therefore, the lactate levels increase in arterial and 
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venous blood only when wash-out of the metabolites with CPR is initiated. Elevated potassium 
levels in the IO samples can be caused by haemolysis from the aspiration. The variation in 
haemoglobin levels in IO samples might be explained by the haematopoiesis in the bone 
marrow. 
 
There is still very little evidence about the use of the IO blood samples during human CA. In 
clinical practice, if venous or arterial blood samples are unavailable, IO samples can be 
considered as a substitute, keeping the physiologic differences and limitations in mind. 
Excluding hyperkalaemia from an IO sample sounds reliable but diagnosing hyperkalaemia as 
a cause of CA from IO samples has a major risk of false positive diagnosis. Though, based on 
this study, the same risk exists with arterial and venous samples. However, when estimating 
the ischemia burden during CA and CPR, IO blood samples might provide better results than 
arterial or venous blood samples.  
 
This study has a number of strengths. Because it used a standardised experimental 
resuscitation model, we were able to obtain simultaneous IO, arterial and venous POC samples 
at precisely defined time points, which makes the comparison of the values reliable. The 
curves (Fig. 2–3) clearly illustrate the different changes in the analysed values during the 
course of the CA and CPR, and they show that POC analyses yield different results from the IO, 
arterial and venous samples. The timeline of the experiment simulates real-life resuscitations, 
as the timing of the resuscitation blood samples parallels the time when paramedics or 
emergency doctors in real life would likely open the vascular access and draw blood samples 
for POC analysis. Nonetheless, some limitations are worth mentioning. First, the pigs were 
healthy before the electrically induced VF. Severely abnormal pre-arrest laboratory values 
were not present, which does not represent real-life situations. A second limitation is the small 
sample size. We excluded several IO-samples because of a potential bias in the results caused 
by obstruction of the blood flow in the femoral artery. However, sensitivity analysis with a 
complete set of samples (i.e. including previously excluded samples) showed no significant 
differences within the results. Statistical proving of the null hypothesis is theoretically 
impossible with this set of samples; thus, the conclusions are based on comparison of the 
values and their variance. 
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 Conclusions 
 
We conclude that, as expected, there is a dynamic change in the POC laboratory values during 
CA and CPR, and arterial, central venous and IO values change differently. The results of POC 
analyses of IO samples during CPR were similar to those of arterial or venous blood and may 
thus represent an alternative for the evaluation of lactate, pH, sodium and calcium. The 
potassium values in the venous, arterial and IO POC samples during CPR were higher than the 
pre-arrest values, leading to a risk of false interpretation of hyperkalaemia as a cause of the 
CA.  
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Legends to figures 
Figure 1 
Timeline of the experiment 
 
T0   Blood sample at baseline before induction of VF 
T1   Blood sample 5 minutes after induction of VF 
T2   Blood sample 5 minutes after initiation of CPR 
T3   Blood sample 10 minutes after ROSC 
VF           Ventricular fibrillation 
CPR       Ventilation (FiO2 50% or 100%) and chest compressions (100/min) with 
LUCAS TM 
Advanced CPR        Defibrillation every 2 min, adrenalin 1 mg every 2 min until ROSC or at 
least 20 min 
ROSC      Return of spontaneous circulation  
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Figures 2 
 
Parameters analysed from arterial, venous and IO samples at four consecutive time 
points. Data are presented as the means with 95% CI. 
 
BL   Baseline, before induction of VF  
VF   Five minutes after induction of VF 
RESUSC  Five minutes after initiation of CPR 
ROSC   Ten minutes after ROSC 
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Legend for Figure 3 
 
Parameters analysed from arterial, venous and IO samples at four consecutive time 
points. Data are presented as the means with 95% CI. 
 
BL   Baseline, before induction of VF  
VF   Five minutes after induction of VF 
RESUSC  Five minutes after initiation of CPR 
ROSC   Ten minutes after ROSC 
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Figures 4 
 
The figures demonstrate how the laboratory values from artery, IO and vein during 
resuscitation differ from the pre-arrest arterial values. Medians, IQRs and ranges are 
displayed.  
 
 
ART Difference RESUSC ARTERY minus BASELINE ARTERY 
VEIN Difference RESUSC VEIN minus BASELINE ARTERY 
IO Difference RESUSC IO minus BASELINE ARTERY 
 
 
Legend for Figure 5 
 
The figures demonstrate how the laboratory values from artery, IO and vein 
during resuscitation differ from the pre-arrest arterial values. Medians, IQRs 
and ranges are displayed.  
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ART Difference RESUSC ARTERY minus BASELINE ARTERY 
VEIN Difference RESUSC VEIN minus BASELINE ARTERY 
IO Difference RESUSC IO minus BASELINE ARTERY 
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